Completed

Phase 2
Age: 21Years - 55Years
MALE
ID00000335

Activity Monitoring Assessment of Opiate Withdrawal

Led by National Institute on Drug Abuse (NIDA) · Updated on 2017-01-31

N/A

Participants Needed

1

Research Sites

8 weeks

Total Duration

On this page

Sponsors

N

National Institute on Drug Abuse (NIDA)

Lead Sponsor

W

Washington D.C. Veterans Affairs Medical Center

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this study is to determine if hyperactivity accompanies abrupt opiate withdrawal in heroin addicts, to determine if computerized solid state activity monitors are capable of quantifying hyperactivity, and to quantify the physical and affective symptoms occurring during abrupt withdrawal in heroin addicts and morphine's capacity to alleviate these symptoms.

CONDITIONS

Official Title

Activity Monitoring Assessment of Opiate Withdrawal - 4

Who Can Participate

Age: 21Years - 55Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

Please contact site for information.

Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

Trial Site Locations

Total: 1 location

1

Washington DC VA

Washington D.C., District of Columbia, United States, 20422

Status Unknown

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

TREATMENT

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here